Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis-3-Year data of the ESTHER trial

Seminars in Arthritis and Rheumatism

Volumn 45, Issue 4, 2016, Pages 404-410

  Song, In Ho ^a   Hermann, Kay Geert ^a   Haibel, Hildrun ^a   Althoff, Christian E ^a   Poddubnyy, Denis ^a   Listing, Joachim ^b   Weiß, Anja ^b   Freundlich, Bruce ^c   Lange, Ekkehard ^d   Rudwaleit, Martin ^a,e   Sieper, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Rheumatism Research Center   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d PFIZER INC   (United States)

^e OWL University   (Germany)

Author keywords

Ankylosing spondylitis; Axial spondyloarthritis; Magnetic resonance imaging; Radiographic progression; TNF alpha blocker

Indexed keywords

ETANERCEPT;

ADULT; ANKYLOSING SPONDYLITIS; ARTHROPATHY; ARTICLE; AXIAL SPONDYLOARTHRITIS; BONE EROSION; CLINICAL ARTICLE; FATTY JOINT LESION; FEMALE; HUMAN; MALE; OSTEITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SACROILIITIS; SCORING SYSTEM; SPONDYLARTHRITIS; WHOLE BODY MRI; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SACROILIAC JOINT; SEVERITY OF ILLNESS INDEX; SPINE; WHOLE BODY IMAGING; YOUNG ADULT;

ADULT; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; SACROILIAC JOINT; SEVERITY OF ILLNESS INDEX; SPINE; SPONDYLARTHRITIS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84959469784     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2015.08.005     Document Type: Article

References (25)

1. van der Linden S., Valkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368.
2. Rudwaleit M., van der Heijde D., Landewe R., Listing J., Akkoc N., Brandt J., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68:777-783.
3. Brophy S., Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 2001, 28(10):2283-2288.
4. Baraliakos X., Listing J., von der Recke A., Braun J. The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients. J Rheumatol 2009, 36(5):997-1002.
5. Poddubnyy D., Rudwaleit M., Haibel H., Listing J., Marker-Hermann E., Zeidler H., et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011, 70(8):1369-1374.
6. Poddubnyy D., Haibel H., Listing J., Marker-Hermann E., Zeidler H., Braun J., et al. Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 2012, 64(5):1388-1398.
7. Sieper J., Appel H., Braun J., Rudwaleit M. Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008, 58(3):649-656.
8. Maksymowych W.P., Morency N., Conner-Spady B., Lambert R.G. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis 2013, 72:23-28.
9. Chiowchanwisawakit P., Lambert R.G., Conner-Spady B., Maksymowych W.P. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011, 63:2215-2225.
10. Maksymowych W.P., Chiowchanwisawakit P., Clare T., Pedersen S.J., Ostergaard M., Lambert R.G. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009, 60:93-102.
11. Song I.H., Hermann K.G., Haibel H., Althoff C.E., Poddubnyy D., Listing J., et al. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Ann Rheum Dis 2011, 70:1257-1263.
12. Baraliakos X., Heldmann F., Callhoff J., Listing J., Appelboom T., Brandt J., et al. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. Ann Rheum Dis 2014, 73:1819-1825.
13. Wanders A., Landewe R., Spoorenberg A., de Vlam K., Mielants H., Dougados M., et al. Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order. Ann Rheum Dis 2004, 63:1601-1604.
14. van der Heijde D., Landewe R., Baraliakos X., Houben H., van Tubergen A., Williamson P., et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008, 58:3063-3070.
15. van der Heijde D., Landewe R., Einstein S., Ory P., Vosse D., Ni L., et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008, 58:1324-1331.
16. van der Heijde D., Salonen D., Weissman B.N., Landewe R., Maksymowych W.P., Kupper H., et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009, 11:R127.
17. Weber U., Pedersen S.J., Ostergaard M., Rufibach K., Lambert R.G., Maksymowych W.P. Can erosions on MRI of he sacroiliac joints be reliably detected in patients with ankylosing spondylitis? A cross-sectional study. Arthritis Res Ther 2012, 14:R124.
18. Song I.H., Hermann K., Haibel H., Althoff C., Listing J., Burmester G., et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 2011, 70:590-596.
19. Song I.H., Althoff C.E., Haibel H., Hermann K.G., Poddubnyy D., Listing J., et al. Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial. Ann Rheum Dis 2012, 71:1212-1215.
20. Krohn M., Braum L.S., Sieper J., Song I.H., Weiss A., Callhoff J., et al. Erosions and fatty lesions of sacroiliac joints in patients with axial spondyloarthritis: evaluation of different MRI techniques and two scoring methods. J Rheumatol 2014, 41:473-480.
21. Haroon N., Inman R.D., Learch T.J., Weisman M.H., Lee M., Rahbar M.H., et al. The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013, 65:2645-2654.
22. Baraliakos X., Haibel H., Listing J., Sieper J., Braun J. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 2014, 73:710-715.
23. Maksymowych W.P., Wichuk S., Chiowchanwisawakit P., Lambert R.G., Pedersen S.J. Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis. Arthritis Rheumatol 2014, 66:2958-2967.
24. Pedersen S.J., Wichuk S., Chiowchanwisawakit P., Lambert R.G., Maksymowych W.P. Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis. Arthritis Res Ther 2014, 16:R100.
25. Pedersen S.J., Zhao Z., Lambert R.G., Wichuk S., Ostergaard M., Weber U., et al. The FAt Spondyloarthritis Spine Score (FASSS): development and validation of a new scoring method for the evaluation of fat lesions in the spine of patients with axial spondyloarthritis. Arthritis Res Ther 2013, 15:R216.